Raut M - Search Results

1

Hidden costs associated with venous thromboembolism: impact of lost productivity on employers and employees.

Page RL 2nd, Ghushchyan V, Gifford B, Read RA, Raut M, Bookhart BK, Naim AB, Damaraju CV, Nair KV. Page RL 2nd, et al. Among authors: raut m. J Occup Environ Med. 2014 Sep;56(9):979-85. doi: 10.1097/JOM.0000000000000208. J Occup Environ Med. 2014. PMID: 25046319

2

The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.

Page RL 2nd, Ghushchyan V, Gifford B, Read RA, Raut M, Crivera C, Naim AB, Damaraju CV, Nair KV. Page RL 2nd, et al. Among authors: raut m. J Occup Environ Med. 2013 Jul;55(7):761-7. doi: 10.1097/JOM.0b013e318297323a. J Occup Environ Med. 2013. PMID: 23787565

3

Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.

Merli GJ, Hollander JE, Lefebvre P, Laliberté F, Raut MK, Germain G, Bookhart B, Pollack CV. Merli GJ, et al. J Med Econ. 2016;19(1):84-90. doi: 10.3111/13696998.2015.1096274. Epub 2015 Oct 27. J Med Econ. 2016. PMID: 26390315 Free article.

4

Prescribers' behavior following below- versus above-range international normalized ratio values in warfarin-treated deep vein thrombosis patients.

Raut MK, Nelson WW, Wang SW, Coleman CI, Lu L, Patel D, Schein JR, Xiang J, Damaraju CV. Raut MK, et al. Curr Med Res Opin. 2016 Jul;32(7):1213-5. doi: 10.1185/03007995.2016.1164678. Epub 2016 Mar 17. Curr Med Res Opin. 2016. PMID: 26960249

5

Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.

Raut M, Schein J, Mody S, Grant R, Benson C, Olson W. Raut M, et al. Curr Med Res Opin. 2009 Sep;25(9):2151-7. doi: 10.1185/03007990903102743. Curr Med Res Opin. 2009. PMID: 19601711

6

Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.

Suh DC, Sung J, Gause D, Raut M, Huang J, Choi IS. Suh DC, et al. Among authors: raut m. J Manag Care Pharm. 2007 Nov-Dec;13(9):778-89. doi: 10.18553/jmcp.2007.13.9.778. J Manag Care Pharm. 2007. PMID: 18062729 Free PMC article.

7

Treatment patterns, health care resource utilization, and costs in patients with relapsed/refractory Hodgkin lymphoma treated with brentuximab vedotin.

Shao C, Liu J, Zhou W, Raut MK, Monberg M, Cao X, Ricart AD, Balakumaran A. Shao C, et al. Among authors: raut mk. Leuk Lymphoma. 2019 Apr;60(4):947-954. doi: 10.1080/10428194.2018.1508665. Epub 2018 Sep 20. Leuk Lymphoma. 2019. PMID: 30234407

8

Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.

Delea TE, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G. Delea TE, et al. Among authors: raut m. J Thorac Oncol. 2006 Jul;1(6):571-6. J Thorac Oncol. 2006. PMID: 17409919 Free article.

9

Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.

Mearns ES, Kohn CG, Song JS, Hawthorne J, Meng J, White CM, Raut MK, Schein JR, Coleman CI. Mearns ES, et al. Thromb Res. 2014 Aug;134(2):310-9. doi: 10.1016/j.thromres.2014.05.035. Epub 2014 Jun 2. Thromb Res. 2014. PMID: 24935672 Review.

10

Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States.

Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Yang X, et al. Among authors: raut m. J Med Econ. 2021 Jan-Dec;24(1):469-478. doi: 10.1080/13696998.2021.1908001. J Med Econ. 2021. PMID: 33784916 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters